Haemonetics | 10-Q: Q2 2025 Earnings Report
Haemonetics | 8-K: Haemonetics Reports Second Quarter and First Half Fiscal 2025 Results; Updates Fiscal 2025 Guidance
Haemonetics | 10-Q: Q1 2025 Earnings Report
Haemonetics | 8-K: Haemonetics Reports First Quarter Fiscal 2025 Results; Reaffirms Fiscal 2025 Guidance
Haemonetics | 10-K: FY2024 Annual Report
Haemonetics | 8-K: Haemonetics Reports Fourth Quarter and Fiscal 2024 Results; Provides Fiscal 2025 Guidance
Haemonetics | 10-Q: Q3 2024 Earnings Report
Haemonetics | 8-K: Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2024 Results; Updates Fiscal 2024 Guidance
Haemonetics | 10-Q: Q2 2024 Earnings Report
Haemonetics | 8-K: Haemonetics Reports Second Quarter and First Half Fiscal 2024 Results; Updates Fiscal 2024 Guidance
Haemonetics | 10-Q: Q1 2024 Earnings Report
Haemonetics | 8-K: Haemonetics Reports First Quarter Fiscal 2024 Results; Updates Fiscal 2024 Guidance
Haemonetics | 10-K: FY2023 Annual Report
Haemonetics | 8-K: Haemonetics Reports Fourth Quarter and Fiscal 2023 Results; Provides Fiscal 2024 Guidance
Haemonetics | 10-Q: Q3 2023 Earnings Report
Haemonetics | 8-K: Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2023 Results; Updates Fiscal 2023 Guidance
Haemonetics | 10-Q: Q2 2023 Earnings Report
Haemonetics | 8-K: Haemonetics Reports Second Quarter and First Half Fiscal 2023 Results; Updates Fiscal 2023 Guidance
Haemonetics | 10-Q: Q1 2023 Earnings Report
Haemonetics | 8-K: Haemonetics Reports First Quarter Fiscal 2023 Results; Updates Fiscal 2023 Guidance; Announces New $300 Million Share Repurchase Authorization
No Data